251 related articles for article (PubMed ID: 24911119)
1. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
[TBL] [Abstract][Full Text] [Related]
3. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
[TBL] [Abstract][Full Text] [Related]
4. The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.
Oh TG; Wang SM; Acharya BR; Goode JM; Graham JD; Clarke CL; Yap AS; Muscat GEO
EBioMedicine; 2016 Apr; 6():59-72. PubMed ID: 27211549
[TBL] [Abstract][Full Text] [Related]
5. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
[TBL] [Abstract][Full Text] [Related]
6. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.
Zhong J; Cao RX; Hong T; Yang J; Zu XY; Xiao XH; Liu JH; Wen GB
Gene; 2011 Nov; 487(1):1-9. PubMed ID: 21820040
[TBL] [Abstract][Full Text] [Related]
7. PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation.
Hu G; Yan C; Xie P; Cao Y; Shao J; Ge J
Exp Cell Res; 2020 Sep; 394(2):112152. PubMed ID: 32574605
[TBL] [Abstract][Full Text] [Related]
8. PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression.
Li Z; Chen C; Yong H; Jiang L; Wang P; Meng S; Chu S; Li Z; Guo Q; Zheng J; Bai J; Li H
Cell Death Dis; 2023 May; 14(5):322. PubMed ID: 37173306
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
[TBL] [Abstract][Full Text] [Related]
10. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium-induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation.
Li J; Pan X; Ren Z; Li B; Liu H; Wu C; Dong X; de Vos P; Pan LL; Sun J
Br J Pharmacol; 2022 Jan; 179(1):141-158. PubMed ID: 34599829
[TBL] [Abstract][Full Text] [Related]
13. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
14. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
[TBL] [Abstract][Full Text] [Related]
16. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
17. PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.
Meyer R; Wolf SS; Obendorf M
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):1-14. PubMed ID: 17587566
[TBL] [Abstract][Full Text] [Related]
18. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
Dowhan DH; Harrison MJ; Eriksson NA; Bailey P; Pearen MA; Fuller PJ; Funder JW; Simpson ER; Leedman PJ; Tilley WD; Brown MA; Clarke CL; Muscat GE
Endocr Relat Cancer; 2012 Aug; 19(4):509-26. PubMed ID: 22673335
[TBL] [Abstract][Full Text] [Related]
20. Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair.
Liu L; Lin B; Yin S; Ball LE; Delaney JR; Long DT; Gan W
Sci Adv; 2022 Dec; 8(49):eadd8928. PubMed ID: 36475791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
